DEFINITIVE PROXY STATEMENT

Company

CITIUS ONCOLOGY, INC.

Filed

September 26, 2025

Period of Report

October 27, 2025

Accession Number

0001213900-25-092369

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →